Penumbra price target raised to $235 from $225 at Piper Sandler

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Penumbra (PEN) to $235 from $225 and keeps an Overweight rating on the shares. The firm notes Penumbra reported Q3 results that beat consensus estimates on the top- and bottom-line. Full-year sales guidance was reiterated, though management raised the lower end of the guidance range for U.S. thrombectomy, Piper adds.